• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过数据关联监测新西兰国家宫颈癌筛查计划的执行情况。

Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.

作者信息

Lewis Hazel, Yeh Li-Chia, Almendral Bobby, Neal Harold

机构信息

National Screening Unit, Ministry of Health, P O Box 5013, Wellington, New Zealand.

出版信息

N Z Med J. 2009 Oct 30;122(1305):15-25.

PMID:19966874
Abstract

AIM

To describe the method developed by the National Cervical Screening Programme (NCSP) for review of cases of cervical cancer; present results from the first 4 years of the review and compare these results with those of the earlier New Zealand Cervical Cancer Audit.

METHODS

Linkage of cervical cancer registrations from the New Zealand Cancer Registry to smear histories from the NCSP Register via the National Health Index, for the 4-year period 2003-06.

RESULTS

A total of 625 women were registered with cervical cancer from 2003-06, of whom 438 were eligible for linkage (women diagnosed with squamous or adenosquamous cervical cancer at <80 years of age). Of these 438 eligible cases, 348 were histologically invasive and 90 were microinvasive. Unlike histological stage, clinical FIGO stage was missing in approximately 50%. Linkage to screening history revealed that 202 of the 438 eligible women (46%) had never been enrolled in the NCSP; 137 (31%) were enrolled but had only been infrequently or irregularly screened; and 85 (20%) developed cancer despite regular screening (data were missing for 3 women). These results were similar to those found in the New Zealand Cervical Cancer Audit, covering the period 2000-2002.

CONCLUSIONS

Ongoing linkage of cancer data to screening data can be used to monitor the performance of the NCSP. Our finding that 80% of potentially preventable cervical cancers involve women who are not enrolled in the Programme or who have been only infrequently and irregularly screened, confirms that improving Programme coverage (currently around 72%) remains a priority. Further investigation (phase 2) is required for the small number of women who develop cervical cancer despite regular screening (average of 21 per year, or approximately 20% of eligible cases), to distinguish interval cancers from possible Programme quality issues.

摘要

目的

描述国家宫颈癌筛查计划(NCSP)所制定的宫颈癌病例审查方法;呈现审查头4年的结果,并将这些结果与早期新西兰宫颈癌审计结果进行比较。

方法

在2003 - 2006年的4年期间,通过国家健康指数将新西兰癌症登记处的宫颈癌登记信息与NCSP登记处的涂片病史进行关联。

结果

2003 - 2006年共有625名女性登记患有宫颈癌,其中438名符合关联条件(年龄小于80岁、被诊断为鳞状或腺鳞癌的女性)。在这438例符合条件的病例中,348例为组织学浸润性癌,90例为微浸润癌。与组织学分期不同,约50%的病例缺少临床国际妇产科联盟(FIGO)分期。与筛查病史的关联显示,438例符合条件的女性中,202例(46%)从未参加过NCSP;137例(31%)已登记,但筛查频率低或不规律;85例(20%)尽管定期筛查仍患癌(3名女性数据缺失)。这些结果与2元000 - 2002年期间新西兰宫颈癌审计的结果相似。

结论

癌症数据与筛查数据的持续关联可用于监测NCSP的绩效。我们发现80%的潜在可预防宫颈癌涉及未参加该计划或筛查频率低且不规律的女性,这证实提高计划覆盖率(目前约为72%)仍然是优先事项。对于少数尽管定期筛查仍患宫颈癌的女性(平均每年21例,约占符合条件病例的20%),需要进一步调查(第二阶段),以区分间隔期癌症与可能的计划质量问题。

相似文献

1
Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.通过数据关联监测新西兰国家宫颈癌筛查计划的执行情况。
N Z Med J. 2009 Oct 30;122(1305):15-25.
2
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
3
Cervical cancer screening: A Slovenian experience.宫颈癌筛查:斯洛文尼亚的经验
Coll Antropol. 2007 Apr;31 Suppl 2:23-6.
4
Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.宫颈癌的诊断途径:筛查史、随访延迟及涂片解读
BJOG. 2007 Apr;114(4):398-407. doi: 10.1111/j.1471-0528.2006.01207.x. Epub 2006 Dec 12.
5
Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.产前巴氏涂片检查对宫颈癌筛查项目覆盖率的影响:一项基于人群的前瞻性研究。
BMC Health Serv Res. 2007 Jan 23;7:10. doi: 10.1186/1472-6963-7-10.
6
Audit of cervical screening in women with HIV infection in the Auckland and Northland regions of New Zealand.对新西兰奥克兰和北地地区感染艾滋病毒女性的宫颈筛查审计。
N Z Med J. 2010 Jul 30;123(1319):71-8.
7
Clinical impact of quality assurance in an organized cervical screening program.
Acta Obstet Gynecol Scand. 1999 May;78(5):429-35.
8
High-grade cervical abnormalities and screening intervals in New South Wales, Australia.澳大利亚新南威尔士州的高级别宫颈异常与筛查间隔
J Med Screen. 2008;15(1):36-43. doi: 10.1258/jms.2008.007036.
9
The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.国家宫颈筛查计划对坎特伯雷地区宫颈癌发病情况的影响。
N Z Med J. 2001 Aug 24;114(1138):378-80.
10
Let's talk about smear tests: social marketing for the National Cervical Screening Programme.让我们谈谈涂片检查:国家子宫颈筛查计划的社会营销。
Public Health. 2009 Sep;123 Suppl 1:e17-22. doi: 10.1016/j.puhe.2009.06.006. Epub 2009 Sep 8.

引用本文的文献

1
Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System.宫颈癌负担与在安全网医疗体系中进行预防的机会。
Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1398-1406. doi: 10.1158/1055-9965.EPI-17-0912. Epub 2018 Sep 5.